drug pricing
Inflation Reduction Act ‘Ripple Effect’ Imperils Medicare Drug Access
The inflation Reduction Act of 2022 has triggered an unintended consequence—significantly declining coverage ...
AUGUST 19, 2025
340B Participation May Hamper Biosimilars Uptake
Are hospitals participating in the federal 340B Drug Pricing Program less motivated to prescribe biosimilars over ...
AUGUST 14, 2024
New CMS Rules Aim to Help Patients to Afford, and Stick to, Medications
CMS has released the final part 1 guidance for the new Medicare Prescription Payment Plan, part of President Joe ...
APRIL 19, 2024
Rx Price Hike Data Questioned
An award-winning study found that the Institute for Clinical and Economic Review rejects nearly all (97%) evidence ...
APRIL 19, 2024
Data Supporting Drug Price Hikes Deemed Faulty
The Institute for Clinical and Economic Review (ICER) rejects nearly all (97%) evidence submitted by manufacturers ...
FEBRUARY 29, 2024
Comment on Medicare Prescription Drug Inflation Rebate Program Guidance
CMS is seeking comment from the public about the Medicare Prescription Drug Inflation Rebate Program, which was ...
FEBRUARY 10, 2023
President Outlines Plans to Fight Cancer, Curb COVID-19, Cut Prescription Drug Prices
Cutting prescription drug prices, continuing to control the spread of COVID-19, curbing substance use disorder and ...
MARCH 2, 2022
Will States Take More Action on Prescription Drug Pricing?
Between Medicaid, state employee benefit plans and the individual and small group commercial market, U.S. states ...
OCTOBER 23, 2020
No Aspect of Health Care Will Be Untouched by COVID-19
With the COVID-19 pandemic derailing nearly every aspect of health care, experts are speculating that the ongoing ...
APRIL 27, 2020
At House Drug Pricing Hearing, ASHP Targets DIR Fees, Anti-Competition Strategies
In a statement submitted to the U.S. House Energy and Commerce Subcommittee on Health as part of a hearing held ...
MAY 9, 2019
FDA Issues Guidance on Competitive Generic Therapies
To address the lack of competition between generic and off-patent brand-name drugs, the FDA issued new guidance to ...
FEBRUARY 22, 2019
ASHP Briefs Congress on Drug Pricing, Shortages
ASHP briefed congress about its new report that found the average total drug spending per hospital admission ...
FEBRUARY 7, 2019
